Event Details

Clinical Trials at the Summit 2024 meeting

Jun 8, 2024 from 8:00 AM to 5:30 PM MDT

Presentations on Kodiak's clinical pipeline will be given at the meeting. Specifics of the presentations are below:

Title: Bispecific Anti-IL-6 Anti-VEGF Programs: KSI-501 in Retinal Vascular Disease and KSI-101 in Macular Edema Secondary to Inflammation
Time: 7:49 – 7:53 AM MT
Presenter: Quan Dong Nguyen, M.D., Professor of Ophthalmology and Director of Uveitis and Ocular Inflammation, Byers Eye Institute, Stanford University School of Medicine.

View Presentation

 

 

Title: Update on KSI Programs for Retinal Diseases
Time: 1:10 – 1:14 PM MT
Presenter: Victor Perlroth, M.D., Chief Executive Officer of Kodiak Sciences

View Presentation